title: Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone.
abstract: Stress and anxiety are mainly regulated by amygdala and hypothalamic circuitries involving several neurotransmitter systems and providing physiological responses to peripheral organs via the hypothalamic-pituitary-adrenal axis and other pathways. The role of endogenous opioid peptides in this process is largely unknown. Here we show for the first time that anxiolytic parameters of explorative behavior in mice lacking prodynorphin were increased 2-4-fold in the open field, the elevated plus maze and the light-dark test. Consistent with this, treatment of wild-type mice with selective kappa-opioid receptor antagonists GNTI or norbinaltorphimine showed the same effects. Furthermore, treatment of prodynorphin knockout animals with U-50488H, a selective kappa-opioid receptor agonist, fully reversed their anxiolytic phenotype. These behavioral data are supported by an approximal 30% reduction in corticotropin-releasing hormone (CRH) mRNA expression in the hypothalamic paraventricular nucleus and central amygdala and an accompanying 30-40% decrease in corticosterone serum levels in prodynorphin knockout mice. Although stress-induced increases in corticosterone levels were attenuated in prodynorphin knockout mice, they were associated with minor increases in depression-like behavior in the tail suspension and forced swim tests. Taken together, our data suggest a pronounced impact of endogenous prodynorphin-derived peptides on anxiety, but not stress coping ability and that these effects are mediated via kappa-opioid receptors. The delay in the behavioral response to kappa-opioid receptor agonists and antagonist treatment suggests an indirect control level for the action of dynorphin, probably by modulating the expression of CRH or neuropeptide Y, and subsequently influencing behavior.
authors.affiliation: Department of Pharmacology, Innsbruck Medical University, Innsbruck, Austria.
authors.forename: Walter
authors.initials: W
authors.lastname: Wittmann
authors.forename: Eduard
authors.initials: E
authors.lastname: Schunk
authors.forename: Iris
authors.initials: I
authors.lastname: Rosskothen
authors.forename: Stefano
authors.initials: S
authors.lastname: Gaburro
authors.forename: Nicolas
authors.initials: N
authors.lastname: Singewald
authors.forename: Herbert
authors.initials: H
authors.lastname: Herzog
authors.forename: Christoph
authors.initials: C
authors.lastname: Schwarzer
mesh_terms: D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / Q000494:pharmacology; D000679:Amygdala / Q000378:metabolism; D000818:Animals; D001007:Anxiety / Q000378:metabolism* / Q000503:physiopathology; D001933:Brain Stem / Q000378:metabolism; D003345:Corticosterone / Q000097:blood; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D004399:Dynorphins / Q000502:physiology; D004745:Enkephalins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D005106:Exploratory Behavior; D005260:Female; D006146:Guanidines; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D018782:Maze Learning; D008636:Mesencephalon / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout / Q000378:metabolism; D009019:Morphinans; D009271:Naltrexone / Q000031:analogs & derivatives / Q000494:pharmacology; D009478:Neuropeptide Y / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D009479:Neuropeptides / Q000235:genetics / Q000378:metabolism*; D011498:Protein Precursors / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D011903:Raphe Nuclei / Q000378:metabolism; D017473:Receptors, Opioid, kappa / Q000819:agonists / Q000037:antagonists & inhibitors; D013315:Stress, Psychological / Q000503:physiopathology
chemical_list: C411465:17-cyclopropylmethyl-6,7-didehydro-4,5-epoxy-5'-guanidinyl-3,14-dihydroxyindolo(2',3'-6,7)morphinan; D004745:Enkephalins; D006146:Guanidines; D009019:Morphinans; D009478:Neuropeptide Y; D009479:Neuropeptides; D011498:Protein Precursors; D017473:Receptors, Opioid, kappa; C051844:norbinaltorphimine; D009271:Naltrexone; D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D004399:Dynorphins; D003346:Corticotropin-Releasing Hormone; C033660:preproenkephalin; D003345:Corticosterone
references.citation: Neuroreport. 1999 Nov 8;10(16):3399-403
references.pmid: 10599852
references.citation: Br J Pharmacol. 1997 Oct;122(3):520-4
references.pmid: 9351509
references.citation: Nat Genet. 2000 Apr;24(4):403-9
references.pmid: 10742107
references.citation: Nat Genet. 2000 Apr;24(4):410-4
references.pmid: 10742108
references.citation: Mol Pharmacol. 1998 Jan;53(1):6-13
references.pmid: 9443927
references.citation: Nat Genet. 1998 Jun;19(2):162-6
references.pmid: 9620773
references.citation: Neuron. 1998 Jun;20(6):1093-102
references.pmid: 9655498
references.citation: Brain Res. 1999 Jul 17;835(1):18-26
references.pmid: 10448192
references.citation: Brain. 2006 Mar;129(Pt 3):642-54
references.pmid: 16399805
references.citation: Neuropsychopharmacology. 2006 Apr;31(4):739-50
references.pmid: 16123756
references.citation: Neuropeptides. 2006 Apr;40(2):115-23
references.pmid: 16439015
references.citation: Peptides. 2006 Aug;27(8):2005-11
references.pmid: 16774797
references.citation: Brain Res. 2006 Aug 2;1102(1):135-44
references.pmid: 16806114
references.citation: Neuropsychopharmacology. 2006 Sep;31(9):1928-37
references.pmid: 16292317
references.citation: Amino Acids. 2006 Oct;31(3):251-72
references.pmid: 16820980
references.citation: Brain. 2007 Apr;130(Pt 4):1017-28
references.pmid: 17347252
references.citation: J Comp Neurol. 2007 Oct 20;504(6):702-15
references.pmid: 17722034
references.citation: J Pharmacol Exp Ther. 2007 Dec;323(3):838-45
references.pmid: 17823306
references.citation: Psychopharmacology (Berl). 2008 Jan;195(4):547-57
references.pmid: 17891380
references.citation: Behav Brain Res. 2008 Feb 11;187(1):67-71
references.pmid: 17923159
references.citation: J Neurosci. 2008 Jan 9;28(2):407-14
references.pmid: 18184783
references.citation: Psychoneuroendocrinology. 2008 May;33(4):425-36
references.pmid: 18280051
references.citation: Nat Genet. 2000 Apr;24(4):415-9
references.pmid: 10742109
references.citation: Brain Res. 2000 Apr 10;861(2):288-95
references.pmid: 10760490
references.citation: Eur J Pharmacol. 2000 May 12;396(1):49-52
references.pmid: 10822054
references.citation: Brain Res Mol Brain Res. 2001 Jan 31;86(1-2):70-5
references.pmid: 11165373
references.citation: J Neurosci. 2001 Mar 1;21(5):1779-86
references.pmid: 11222667
references.citation: Brain Res. 2001 Aug 3;909(1-2):75-80
references.pmid: 11478923
references.citation: Neurosci Biobehav Rev. 2002 May;26(3):259-83
references.pmid: 12034130
references.citation: Psychopharmacology (Berl). 2002 Oct;163(3-4):467-76
references.pmid: 12373447
references.citation: Diabetes. 2002 Dec;51(12):3420-7
references.pmid: 12453895
references.citation: Eur J Pharmacol. 2003 Feb 28;463(1-3):117-32
references.pmid: 12600705
references.citation: Int Clin Psychopharmacol. 2003 Jul;18(4):191-202
references.pmid: 12817153
references.citation: J Neurosci. 2003 Jul 2;23(13):5674-83
references.pmid: 12843270
references.citation: Exp Toxicol Pathol. 2003 Jul;55(1):69-83
references.pmid: 12940631
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4280-5
references.pmid: 15024126
references.citation: Life Sci. 2004 Jun 4;75(3):257-70
references.pmid: 15135648
references.citation: Neuropeptides. 2004 Aug;38(4):225-34
references.pmid: 15337374
references.citation: Peptides. 2004 Aug;25(8):1355-63
references.pmid: 15350704
references.citation: Dis Nerv Syst. 1970 Nov;31:Suppl:34-7
references.pmid: 5312689
references.citation: Mt Sinai J Med. 1974 Sep-Oct;41(5):615-25
references.pmid: 4547223
references.citation: Psychopharmacol Bull. 1987;23(1):145-9
references.pmid: 3110855
references.citation: Science. 1993 Jan 22;259(5094):528-31
references.pmid: 8380941
references.citation: Trends Neurosci. 1994 Feb;17(2):80-5
references.pmid: 7512773
references.citation: Ann N Y Acad Sci. 1996 Mar 22;780:36-48
references.pmid: 8602738
references.citation: Eur J Pharmacol. 1996 Jun 20;307(1):7-14
references.pmid: 8831097
references.citation: Gen Pharmacol. 1996 Jun;27(4):673-7
references.pmid: 8853304
references.citation: Physiol Behav. 1996 Oct;60(4):1183-6
references.pmid: 8884951
references.citation: Brain Res. 2000 Feb 28;857(1-2):283-5
references.pmid: 10700578